UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ELF3-GPR37L1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ELF3-GPR37L1 | FusionPDB ID: 26177 | FusionGDB2.0 ID: 26177 | Hgene | Tgene | Gene symbol | ELF3 | GPR37L1 | Gene ID | 1999 | 9283 |
Gene name | E74 like ETS transcription factor 3 | G protein-coupled receptor 37 like 1 | |
Synonyms | EPR-1|ERT|ESE-1|ESX | ET(B)R-LP-2|ETBR-LP-2|ETBRLP2 | |
Cytomap | 1q32.1 | 1q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | ETS-related transcription factor Elf-3E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific)E74-like factor 3 (ets domain transcription factor)E74-like factor 3 (ets domain transcription factor, epithelial-specific )epith | G-protein coupled receptor 37-like 1endothelin B receptor-like protein 2endothelin type b receptor-like protein 2prosaposin receptor GPR37L1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P78545 | O60883 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000495848, ENST00000359651, ENST00000367283, ENST00000367284, | ENST00000367282, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 3 X 3 X 2=18 | 12 X 6 X 7=504 |
# samples | 3 | 16 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(16/504*10)=-1.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ELF3 [Title/Abstract] AND GPR37L1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ELF3(201980427)-GPR37L1(202096869), # samples:2 GPR37L1(202092721)-ELF3(201985008), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ELF3-GPR37L1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ELF3-GPR37L1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ELF3-GPR37L1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ELF3-GPR37L1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ELF3 | GO:0045892 | negative regulation of transcription, DNA-templated | 10773884 |
Hgene | ELF3 | GO:0045893 | positive regulation of transcription, DNA-templated | 9234700 |
Tgene | GPR37L1 | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 23690594 |
Tgene | GPR37L1 | GO:0043410 | positive regulation of MAPK cascade | 23690594 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-VQ-A8E7-01B | ELF3 | chr1 | 201980427 | + | GPR37L1 | chr1 | 202096869 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000359651 | ELF3 | chr1 | 201980427 | + | ENST00000367282 | GPR37L1 | chr1 | 202096869 | + | 9207 | 3355 | 3364 | 4170 | 268 |
ENST00000367284 | ELF3 | chr1 | 201980427 | + | ENST00000367282 | GPR37L1 | chr1 | 202096869 | + | 6213 | 361 | 370 | 1176 | 268 |
ENST00000367283 | ELF3 | chr1 | 201980427 | + | ENST00000367282 | GPR37L1 | chr1 | 202096869 | + | 6257 | 405 | 414 | 1220 | 268 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000359651 | ENST00000367282 | ELF3 | chr1 | 201980427 | + | GPR37L1 | chr1 | 202096869 | + | 0.08225092 | 0.91774905 |
ENST00000367284 | ENST00000367282 | ELF3 | chr1 | 201980427 | + | GPR37L1 | chr1 | 202096869 | + | 0.08339192 | 0.91660804 |
ENST00000367283 | ENST00000367282 | ELF3 | chr1 | 201980427 | + | GPR37L1 | chr1 | 202096869 | + | 0.08068882 | 0.91931117 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >26177_26177_1_ELF3-GPR37L1_ELF3_chr1_201980427_ENST00000359651_GPR37L1_chr1_202096869_ENST00000367282_length(amino acids)=268AA_BP= MGVTTFSLCALGIDRFHVATSTLPKVRPIERCQSILAKLAVIWVGSMTLAVPELLLWQLAQEPAPTMGTLDSCIMKPSASLPESLYSLVM TYQNARMWWYFGCYFCLPILFTVTCQLVTWRVRGPPGRKSECRASKHEQCESQLNSTVVGLTVVYAFCTLPENVCNIVVAYLSTELTRQT -------------------------------------------------------------- >26177_26177_2_ELF3-GPR37L1_ELF3_chr1_201980427_ENST00000367283_GPR37L1_chr1_202096869_ENST00000367282_length(amino acids)=268AA_BP= MGVTTFSLCALGIDRFHVATSTLPKVRPIERCQSILAKLAVIWVGSMTLAVPELLLWQLAQEPAPTMGTLDSCIMKPSASLPESLYSLVM TYQNARMWWYFGCYFCLPILFTVTCQLVTWRVRGPPGRKSECRASKHEQCESQLNSTVVGLTVVYAFCTLPENVCNIVVAYLSTELTRQT -------------------------------------------------------------- >26177_26177_3_ELF3-GPR37L1_ELF3_chr1_201980427_ENST00000367284_GPR37L1_chr1_202096869_ENST00000367282_length(amino acids)=268AA_BP= MGVTTFSLCALGIDRFHVATSTLPKVRPIERCQSILAKLAVIWVGSMTLAVPELLLWQLAQEPAPTMGTLDSCIMKPSASLPESLYSLVM TYQNARMWWYFGCYFCLPILFTVTCQLVTWRVRGPPGRKSECRASKHEQCESQLNSTVVGLTVVYAFCTLPENVCNIVVAYLSTELTRQT -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:201980427/chr1:202096869) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ELF3 | GPR37L1 |
FUNCTION: Transcriptional activator that binds and transactivates ETS sequences containing the consensus nucleotide core sequence GGA[AT]. Acts synergistically with POU2F3 to transactivate the SPRR2A promoter and with RUNX1 to transactivate the ANGPT1 promoter. Also transactivates collagenase, CCL20, CLND7, FLG, KRT8, NOS2, PTGS2, SPRR2B, TGFBR2 and TGM3 promoters. Represses KRT4 promoter activity. Involved in mediating vascular inflammation. May play an important role in epithelial cell differentiation and tumorigenesis. May be a critical downstream effector of the ERBB2 signaling pathway. May be associated with mammary gland development and involution. Plays an important role in the regulation of transcription with TATA-less promoters in preimplantation embryos, which is essential in preimplantation development (By similarity). {ECO:0000250, ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:10644990, ECO:0000269|PubMed:10773884, ECO:0000269|PubMed:11036073, ECO:0000269|PubMed:11313868, ECO:0000269|PubMed:12414801, ECO:0000269|PubMed:12624109, ECO:0000269|PubMed:12682075, ECO:0000269|PubMed:12713734, ECO:0000269|PubMed:14715662, ECO:0000269|PubMed:14767472, ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:15794755, ECO:0000269|PubMed:16307850, ECO:0000269|PubMed:17060315, ECO:0000269|PubMed:9129154, ECO:0000269|PubMed:9234700, ECO:0000269|PubMed:9336459, ECO:0000269|PubMed:9395241, ECO:0000269|PubMed:9417054}. | FUNCTION: G-protein coupled receptor (PubMed:27072655). Has been shown to bind the neuroprotective and glioprotective factor prosaposin (PSAP), leading to endocytosis followed by an ERK phosphorylation cascade (PubMed:23690594). However, other studies have shown that prosaposin does not increase activity (PubMed:27072655, PubMed:28688853). It has been suggested that GPR37L1 is a constitutively active receptor which signals through the guanine nucleotide-binding protein G(s) subunit alpha (PubMed:27072655). Participates in the regulation of postnatal cerebellar development by modulating the Shh pathway (By similarity). Regulates baseline blood pressure in females and protects against cardiovascular stress in males (By similarity). Mediates inhibition of astrocyte glutamate transporters and reduction in neuronal N-methyl-D-aspartate receptor activity (By similarity). {ECO:0000250|UniProtKB:Q99JG2, ECO:0000269|PubMed:23690594, ECO:0000269|PubMed:27072655, ECO:0000269|PubMed:28688853}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 418_439 | 210.0 | 482.0 | Compositional bias | Note=Cys-rich | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 227_251 | 210.0 | 482.0 | Topological domain | Cytoplasmic | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 273_310 | 210.0 | 482.0 | Topological domain | Extracellular | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 332_361 | 210.0 | 482.0 | Topological domain | Cytoplasmic | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 383_398 | 210.0 | 482.0 | Topological domain | Extracellular | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 420_481 | 210.0 | 482.0 | Topological domain | Cytoplasmic | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 252_272 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 311_331 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 362_382 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 399_419 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D7 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000359651 | + | 1 | 8 | 273_355 | 54.333333333333336 | 372.0 | DNA binding | ETS |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367283 | + | 2 | 9 | 273_355 | 54.333333333333336 | 372.0 | DNA binding | ETS |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367284 | + | 2 | 9 | 273_355 | 54.333333333333336 | 372.0 | DNA binding | ETS |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000359651 | + | 1 | 8 | 46_132 | 54.333333333333336 | 372.0 | Domain | PNT |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367283 | + | 2 | 9 | 46_132 | 54.333333333333336 | 372.0 | Domain | PNT |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367284 | + | 2 | 9 | 46_132 | 54.333333333333336 | 372.0 | Domain | PNT |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000359651 | + | 1 | 8 | 137_145 | 54.333333333333336 | 372.0 | Motif | Note=9aaTAD |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367283 | + | 2 | 9 | 137_145 | 54.333333333333336 | 372.0 | Motif | Note=9aaTAD |
Hgene | ELF3 | chr1:201980427 | chr1:202096869 | ENST00000367284 | + | 2 | 9 | 137_145 | 54.333333333333336 | 372.0 | Motif | Note=9aaTAD |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 156_167 | 210.0 | 482.0 | Topological domain | Cytoplasmic | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 189_205 | 210.0 | 482.0 | Topological domain | Extracellular | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 26_134 | 210.0 | 482.0 | Topological domain | Extracellular | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 135_155 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 168_188 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GPR37L1 | chr1:201980427 | chr1:202096869 | ENST00000367282 | 0 | 2 | 206_226 | 210.0 | 482.0 | Transmembrane | Helical%3B Name%3D3 |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ELF3 | |
GPR37L1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ELF3-GPR37L1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ELF3-GPR37L1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |